Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

Evaluation of cerebrospinal fluid phosphorylated tau231 as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia.

Kiđemet-Piskač S, Babić Leko M, Blažeković A, Langer Horvat L, Klepac N, Sonicki Z, Kolenc D, Hof PR, Boban M, Mimica N, Borovečki F, Šimić G.

CNS Neurosci Ther. 2018 Aug;24(8):734-740. doi: 10.1111/cns.12814. Epub 2018 Feb 17.

2.

Cerebrospinal fluid amyloid beta42/phosphorylated tau ratio discriminates between Alzheimer's disease and vascular dementia.

de Jong D, Jansen RW, Kremer BP, Verbeek MM.

J Gerontol A Biol Sci Med Sci. 2006 Jul;61(7):755-8.

PMID:
16870640
3.

Predictive Value of Cerebrospinal Fluid Visinin-Like Protein-1 Levels for Alzheimer's Disease Early Detection and Differential Diagnosis in Patients with Mild Cognitive Impairment.

Babić Leko M, Borovečki F, Dejanović N, Hof PR, Šimić G.

J Alzheimers Dis. 2016;50(3):765-78. doi: 10.3233/JAD-150705.

PMID:
26836160
4.

Greater specificity for cerebrospinal fluid P-tau231 over P-tau181 in the differentiation of healthy controls from Alzheimer's disease.

Spiegel J, Pirraglia E, Osorio RS, Glodzik L, Li Y, Tsui W, Saint Louis LA, Randall C, Butler T, Xu J, Zinkowski RP, Zetterberg H, Fortea J, Fossati S, Wisniewski T, Davies P, Blennow K, de Leon MJ.

J Alzheimers Dis. 2016;49(1):93-100. doi: 10.3233/JAD-150167.

5.

Event-related Potentials Improve the Efficiency of Cerebrospinal Fluid Biomarkers for Differential Diagnosis of Alzheimer's Disease.

Babić Leko M, Krbot Skorić M, Klepac N, Borovečki F, Langer Horvat L, Vogrinc Ž, Sonicki Z, Hof PR, Šimić G.

Curr Alzheimer Res. 2018;15(13):1244-1260. doi: 10.2174/1567205015666180911151116.

PMID:
30207231
6.

The cerebrospinal fluid amyloid beta42/40 ratio in the differentiation of Alzheimer's disease from non-Alzheimer's dementia.

Spies PE, Slats D, Sjögren JM, Kremer BP, Verhey FR, Rikkert MG, Verbeek MM.

Curr Alzheimer Res. 2010 Aug;7(5):470-6.

PMID:
20043812
7.

Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease: a comparative cerebrospinal fluid study.

Hampel H, Buerger K, Zinkowski R, Teipel SJ, Goernitz A, Andreasen N, Sjoegren M, DeBernardis J, Kerkman D, Ishiguro K, Ohno H, Vanmechelen E, Vanderstichele H, McCulloch C, Moller HJ, Davies P, Blennow K.

Arch Gen Psychiatry. 2004 Jan;61(1):95-102.

PMID:
14706948
8.

Cerebrospinal fluid phospho-tau, total tau and beta-amyloid(1-42) in the differentiation between Alzheimer's disease and vascular dementia.

Nägga K, Gottfries J, Blennow K, Marcusson J.

Dement Geriatr Cogn Disord. 2002;14(4):183-90.

PMID:
12411760
9.

Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia.

Boban M, Grbić K, Mladinov M, Hof PR, Süssmair C, Ackl N, Stanić G, Bader B, Danek A, Simić G.

Coll Antropol. 2008 Jan;32 Suppl 1:31-6.

PMID:
18405055
10.

A Pilot Longitudinal Study on Cerebrospinal Fluid (CSF) Tau Protein in Alzheimer's Disease and Vascular Dementia.

Wang H, Wang T, Qian S, Ba L, Lin Z, Xiao S.

Shanghai Arch Psychiatry. 2016 Oct 25;28(5):271-279. doi: 10.11919/j.issn.1002-0829.216068.

11.

Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.

Buerger K, Otto M, Teipel SJ, Zinkowski R, Blennow K, DeBernardis J, Kerkman D, Schröder J, Schönknecht P, Cepek L, McCulloch C, Möller HJ, Wiltfang J, Kretzschmar H, Hampel H.

Neurobiol Aging. 2006 Jan;27(1):10-5.

PMID:
16298235
12.

The role of CSF biomarkers in the diagnostic work-up of mixed vascular-degenerative dementia.

Engelborghs S, Le Bastard N.

J Neurol Sci. 2012 Nov 15;322(1-2):197-9. doi: 10.1016/j.jns.2012.08.003. Epub 2012 Sep 2.

PMID:
22947896
13.

CSF lactate levels, τ proteins, cognitive decline: a dynamic relationship in Alzheimer's disease.

Liguori C, Stefani A, Sancesario G, Sancesario GM, Marciani MG, Pierantozzi M.

J Neurol Neurosurg Psychiatry. 2015 Jun;86(6):655-9. doi: 10.1136/jnnp-2014-308577. Epub 2014 Aug 13.

PMID:
25121572
14.

Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patients with Alzheimer's disease and vascular dementia.

Ravaglia S, Bini P, Sinforiani E, Franciotta D, Zardini E, Tosca P, Moglia A, Costa A.

Neurol Sci. 2008 Dec;29(6):417-23. doi: 10.1007/s10072-008-1023-1. Epub 2008 Nov 14.

PMID:
19011737
15.

Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein.

Grangeon L, Paquet C, Bombois S, Quillard-Muraine M, Martinaud O, Bourre B, Lefaucheur R, Nicolas G, Dumurgier J, Gerardin E, Jan M, Laplanche JL, Peoc'h K, Hugon J, Pasquier F, Maltête D, Hannequin D, Wallon D; collaborators of the ePLM.fr group.

J Alzheimers Dis. 2016;51(3):905-13. doi: 10.3233/JAD-151111.

PMID:
26890785
16.

Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.

Chiasserini D, Biscetti L, Eusebi P, Salvadori N, Frattini G, Simoni S, De Roeck N, Tambasco N, Stoops E, Vanderstichele H, Engelborghs S, Mollenhauer B, Calabresi P, Parnetti L.

Alzheimers Res Ther. 2017 Jul 28;9(1):52. doi: 10.1186/s13195-017-0276-4.

17.

Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias.

Herbert MK, Aerts MB, Kuiperij HB, Claassen JAHR, Spies PE, Esselink RAJ, Bloem BR, Verbeek MM.

Alzheimers Dement. 2014 Jul;10(4):448-455.e2. doi: 10.1016/j.jalz.2013.05.1775. Epub 2013 Nov 13.

PMID:
24239248
18.

Cerebrospinal fluid matrix metalloproteinases and tissue inhibitor of metalloproteinases in combination with subcortical and cortical biomarkers in vascular dementia and Alzheimer's disease.

Bjerke M, Zetterberg H, Edman Å, Blennow K, Wallin A, Andreasson U.

J Alzheimers Dis. 2011;27(3):665-76. doi: 10.3233/JAD-2011-110566.

PMID:
21860087
19.

Cerebrospinal fluid τ protein in differential diagnosis of Alzheimer's disease and vascular dementia in Chinese population: a meta-analysis.

Liu B, Tang Y, Shen Y, Cen L, Han M.

Am J Alzheimers Dis Other Demen. 2014 Mar;29(2):116-22. doi: 10.1177/1533317513507374. Epub 2013 Oct 27.

PMID:
24164930
20.

Cerebrospinal fluid biomarkers in Alzheimer's disease, vascular dementia and ischemic stroke patients: a critical analysis.

Kaerst L, Kuhlmann A, Wedekind D, Stoeck K, Lange P, Zerr I.

J Neurol. 2013 Nov;260(11):2722-7. doi: 10.1007/s00415-013-7047-3. Epub 2013 Jul 23.

Supplemental Content

Support Center